Pop Mart International Group Limited

The company was supported by the Chinese government's new measures to stimulate consumption

Shares of Labooboo's creator posted their biggest gain since August. Do they still have potential?

NVIDIA Corporation

Taiwan Semiconductor Manufacturing Company Limited

Intel Corporation

Leading Chinese companies - Alibaba and ByteDance - are training their artificial intelligence models abroad to gain access to Nvidia chips, Financial Times sources claim. One of China's largest developers, Vanke, has requested a delay in payments, causing its bonds to collapse and alarm across the sector. On these and other topics - in our review of key events by the morning of November 27.

Highlights for the morning: Canada's duties, Intel and TSMC squabble, China finds its way to Nvidia chips

Li Auto Inc.

Electric car maker reports sharp drop in revenue

Shorts made record bets against Li Auto stock. What made them wary?

With India's GDP growth forecast at 6-7% and corporate profits growing at double-digit rates, the idea of moving into Indian equities looks compelling, the bank said 

JPMorgan Chase urged to shift from Chinese stocks to Indian stocks

Wingtech Technology Co.,Ltd

The Netherlands has suspended its powers over chip maker Nexperia, returning control of the company to its Chinese shareholder, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-11-19/dutch-hand-back-control-of-chinese-owned-chipmaker-nexperia">reports</a>. The <a href="https://www.government.nl/latest/news/2025/10/12/minister-of-economic-affairs-invokes-goods-availability-act">order</a>, which gave the Netherlands the right to block or review Nexperia's decisions, was lifted as a "goodwill gesture," Economy Minister Vincent Carremans <a href="https://x.com/MinisterEZ/status/1991065975148433517">said</a> in a post on social network X.

The Netherlands has returned control of Nexperia to China. What does this mean for the automotive industry?

Apple Inc.

Every fourth smartphone sold in China in October was an iPhone, Bloomberg <a href="https://www.bloomberg.com/news/articles/2025-11-18/apple-s-iphone-sales-surge-in-china-to-take-25-market-share">writes,</a> citing data from the analytical company Counterpoint Research. Apple's share of the Chinese market reached 25% for the first time since 2022.

Apple's share in China reached 25% for the first time since 2022 thanks to iPhone 17 sales

BYD Company Limited

Agricultural Bank of China Limited

China Construction Bank Corporation

Industrial and Commercial Bank of China Limited

Geely Automobile Holdings Limited

Zhejiang Leapmotor Technology Co., Ltd.

The Chinese economy, which never tires of impressing with its achievements in a number of technological sectors, is actually standing on the edge of a dangerous precipice: it is slipping into a deflationary spiral. What is the danger?

China's deflationary trap: which companies and industries will fall into it? 

Shiseido Company, Limited

Pan Pacific International Holdings Corporation

Trip.com Group Limited

The risk of a boycott of Japanese goods in China could hit sales of Uniqlo, Asics and Muji

China has warned the public against traveling to Japan. Which stocks are affected?

Sales of iPhones in China grew by 22% in October - the first month after the release of the iPhone 17 lineup - compared to the same period last year, Reuters <a href="https://www.reuters.com/world/china/apples-china-iphone-sales-jumped-22-month-after-iphone-17-launch-2025-11-14/">writes,</a> citing data from research company Counterpoint. This happened despite the general weakening of the smartphone market in the country, the agency notes.

iPhone sales in China up 22% after the release of the new lineup

Burberry Group plc

Sales in the region that includes China rose 3% after falling 5%

Burberry reported sales growth in China. Is everything so rosy in this market?

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Akeso, Inc.

Legend Biotech Corporation

3SBio Inc.

BeOne Medicines AG

Innovent Biologics, Inc.

In 2025, biotech companies from China are likely to renew the record for the sixth consecutive year in terms of the volume of deals with Western pharma giants actively buying up the rights to develop and sell Chinese drugs. Ilya Zubkov, Freedom Broker's senior analyst for the healthcare sector, has selected seven companies that investors looking to capitalize on the growth of Chinese biotech should pay attention to.

China's biotech companies are booming. How to capitalize on it? 

LVMH Moet Hennessy - Louis Vuitton, Societe Europeenne

Last year, sales of luxury goods in the Chinese market fell by nearly 20 percent